How Has the Lancing Devices And Equipment Market Evolved Historically and What is its Current Size?
The lancing devices and equipment market has seen considerable growth due to a variety of factors.
• In recent times, a significant growth has been observed in the market size of lancing devices and equipment. An increase from $3.06 billion in 2024 to $3.35 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%, is expected.
Factors such as the growing prevalence of diabetes, convenience for patients, in-home monitoring, and digitization in healthcare are believed to fuel the historical growth period.
What is the Forecasted Market Size and CAGR for the Lancing Devices And Equipment Market?
The lancing devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for lancing devices and equipment is projected to experience robust growth. It's projected to increase to $4.78 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%.
This growth during the forecast period can be ascribed to the ongoing diabetes outbreak, improvements in testing precision, telehealth and remote monitoring, as well as personalized medicine. Key trends anticipated during the forecast timeframe encompass the incorporation of continuous glucose monitoring (CGM), non-invasive glucose monitoring, user-centered designs, and the use of sustainable and eco-friendly materials.
What Key Factors and Trends Are Driving The Growth Lancing Devices And Equipment Market?
The escalating incidence of diabetes worldwide is propelling the lancing devices and equipment market, given the increasing dependency on these devices for testing blood glucose levels. Lancing devices are essential for diabetics as they enable the collection of blood samples for determining glucose concentrations. According to the IDF Diabetes Atlas, a Belgium-based global resource offering exhaustive data and insights into global diabetes prevalence, care, and treatment, the worldwide incidence of diabetes is expected to rise from 643 million in 2030 to 783 million by 2045, thus leading to an additional 140 million cases. Presently, diabetes is a common health condition among 537 million adults, the majority of who reside in developing nations. It is anticipated that this surge in the diabetic population will bolster the demand for lancing devices and equipment, consequently fueling the growth of the market.
What Are The Market Segments In The Lancing Devices And Equipment Market?
The lancing devices and equipment market covered in this report is segmented –
1) By Type: Reusable, Disposable
2) By Product: Safety Lancets, Standard Lancets
3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths
4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User
Subsegments:
1) By Reusable: Manual Reusable Lancets, Automated Reusable Lancets
2) By Disposable: Pre-filled Disposable Lancets, Single-use Lancets
Pre-Book The Lancing Devices And Equipment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Lancing Devices And Equipment Market?
Manufacturers of lancing devices are progressively integrating personalized vacuum technology into their products to decrease discomfort caused by pricking. These lancing instruments make use of the technology to create a superficial wound on the skin, avoiding deeper pain nerves, and blood is subsequently drawn out via the vacuum. Illustratively, the Genteel Lancing Device is a lancing device that leverages vacuum technology to draw blood from the capillaries and its use is not limited to the fingers; it can be utilized on various parts of the body.
Who Are the Key Players In The Lancing Devices And Equipment Market?
Major companies operating in the lancing devices and equipment market include:
• Abbott laboratories
• B. Braun Melsungen AG
• Terumo Corporation
• F. Hoffmann-La Roche AG
• LifeScan Inc.
• Ascensia Diabetes Care Holdings AG
• Becton Dickinson and Company
• Bayer AG
• Medtronic plc
• ARKRAY Inc.
• Sanofi S.A.
• Ypsomed Holding AG
• Sarstedt AG & Co.
• Greiner Bio-One
• HTL-STREFA S.A
• Guangzhou Improve Medical Instruments Co. Ltd.
• UltiMed Inc.
• Allison Medical Inc.
• Artsana S.p.a.
• Perrigo Diabetes Care
• MedExel Co. Ltd.
• Simple Diagnostics
• Stat Medical Inc.
• Trividia Health
• Eli Lilly and Company
• Roche Diagnostics
• Terumo Corporation
• LifeScan
• Dynarex Corporation
• Dealmed Medical Supplies LLC
• Advanced Diabetic Solutions
• Medline Industries Inc.
• Owen Mumford
• ARKRAY USA Inc.
• Nipro Diagnostics Inc.
• AgaMatrix Inc.
• Nova Biomedical
• Prodigy Diabetes Care LLC
• ACON Laboratories Inc.
What Are The Regional Insights Into The Lancing Devices And Equipment Market?
North America was the largest region in the global lancing devices and equipment market in 2023. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
